New Drugs and Hemopoietic Stem Cell Transplantation in Oncohematological Diseases of the Elderly

Published: 2010-05-03

Guest editors: Giuseppe Leone and Lodovico Balducci

Perspectives

TREATMENT OF CANCER IN THE OLDER AGED PERSON

Lodovico Balducci
DOI https://doi.org/10.4084/mjhid.2010.029

Pages e2010029

PDF HTML

Review Articles

ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

Mohamed L. Sorror, Rainer F. Storb
DOI https://doi.org/10.4084/mjhid.2010.015

Pages e2010015

PDF HTML

CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH

Lisa Pieri, Paola Guglielmelli, Alessandro Maria Vannucchi
DOI https://doi.org/10.4084/mjhid.2010.017

Pages e2010017

PDF HTML

OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING REDUCED-INTENSITY CONDITIONINIG REGIMEN IN PATIENTS WITH IDIOPATHIC MYELOFIBROSIS: THE G.I.T.M.O. EXPERIENCE AND REVIEW OF THE LITERATURE

Francesca Patriarca, Andrea Bacigalupo, Alessandra Sperotto, Miriam Isola, Maria Teresa Van Lint, Anna Paola Iori, Paolo Di Bartolomeo, Maurizio Musso, Pietro Pioltelli, Giuseppe Visani, Pasquale Iacopino, Renato Fanin, Alberto Bosi
DOI https://doi.org/10.4084/mjhid.2010.010

Pages e2010010

PDF HTML

APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA

Tadeusz Robak
DOI https://doi.org/10.4084/mjhid.2010.011

Pages e2010011

PDF HTML

ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA

Luca Laurenti, Michela Tarnani, Patrizia Chiusolo, Federica Sorà, Simona Sica
DOI https://doi.org/10.4084/mjhid.2010.026

Pages e2010026

PDF HTML

THE TREATMENT OF MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE FOR ASCT

Paul Richardson, Jacob Laubach, Anuj Mahindra, Constantine Mitsiades, Robert Schlossman, Irene Ghobrial, Teru Hideshima, Noopur Raje, Nikhil Munshi, Kenneth Anderson
DOI https://doi.org/10.4084/mjhid.2010.009

Pages e2010009

PDF HTML

"ROLE OF ALLOGENEIC TRANSPLANTATION IN MULTIPLE MYELOMA IN THE ERA OF NEW DRUGS"

Benedetto Bruno, Luisa Giaccone, Moreno Festuccia, Mario Boccadoro
DOI https://doi.org/10.4084/mjhid.2010.013

Pages e2010013

PDF HTML

NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES

Francesco D'Alò, Mariangela Greco, Marianna Criscuolo, Maria Teresa Voso
DOI https://doi.org/10.4084/mjhid.2010.021

Pages e2010021

PDF HTML

ROLE AND TIMING OF HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME

Teresa L Field, Claudio Anasetti
DOI https://doi.org/10.4084/mjhid.2010.019

Pages e2010019

PDF HTML

How I Treat

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN THE TREATMENT OF CHRONIC LYMPHOCITIC LEUKEMIA : WHY AND WHEN ?

Maria L. Delioukina, Stephen J. Forman
DOI https://doi.org/10.4084/mjhid.2010.018

Pages e2010018

PDF HTML

Original Articles

POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

Guillermo Jose Ruiz-Delgado, Avril Lopez-Otero, Ana Hernandez-Arizpe, Aura Ramirez-Medina, Guillermo Jose Ruiz-Argüelles
DOI https://doi.org/10.4084/mjhid.2010.016

Pages e2010016

PDF HTML

CLINICAL ANALYSIS AND OPTIMIZATION OF POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH MINIMAL RESIDUAL DISEASE AS DETERMINED BY FLOW CYTOMETRY

Daichi Inoue, Hayato Maruoka, Takayuki Takahashi
DOI https://doi.org/10.4084/mjhid.2010.020

Pages e2010020

PDF HTML

Case Reports

PHENYTOIN-ASSOCIATED LYMPHOADENOPATHY MIMICKING A PERIPHERAL T-CELL LYMPHOMA

Mark E. Johns, Lynn C. Moscinski, Lubomir Sokol
DOI https://doi.org/10.4084/mjhid.2010.028

Pages e2010028

PDF HTML

Letters to Editor

Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia

Alhossain A. Khalafallah, Bernadene Fernandopulle, Terry Brain
DOI https://doi.org/10.4084/mjhid.2010.012

Pages e2010012

PDF HTML